文献速递创伤骨科骨质疏松与代谢性骨病

英国髋部骨折后骨保护药物处方与依从性:WHiTE队列研究

Prescribing and adherence to bone protection medications following hip fracture in the United Kingdom: results from the World Hip Trauma Evaluation (WHiTE) cohort study.
PubMed 文献 · Bone Joint J · 2019-01-01

WHiTE多中心前瞻性队列纳入5456例≥60岁手术治疗的髋部骨折患者,出院时52%被处方骨保护药物,75%被处方维生素D或钙,11%未处方任何药物。在处方骨保护药物的患者中,仅33%在术后120天报告仍在服药。

要点

  • 出院时52%患者被处方骨保护药物,口服双膦酸盐最常见。
  • 75%患者被处方维生素D或钙,11%未处方任何药物。
  • 处方骨保护药物者中仅33%在120天时报告仍在服药。

核心结论

  • 这些数据为当前处方率和依从性提供了参考,髋部骨折患者口服药物依从性仍然较差。

研究设计与样本

  • WHiTE为英格兰和威尔士NHS医院的多中心前瞻性队列,纳入≥60岁接受手术治疗的髋部骨折患者。

主要发现

  • 5456例有基线数据的患者中,2853例(52%)出院时被处方骨保护药物,口服双膦酸盐最常见。
  • 4109例(75%)被处方维生素D或钙,606例(11%)未处方任何药物。
  • 处方骨保护药物的患者中,仅932例(33%)在术后120天报告仍在服药。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Bone health assessment and the prescription of medication for secondary fracture prevention have become an integral part of the acute management of patients with hip fracture. However, there is little evidence regarding compliance with prescription guidelines and subsequent adherence to medication in this patient group. PATIENTS AND METHODS: The World Hip Trauma Evaluation (WHiTE) is a multicentre, prospective cohort of hip fracture patients in NHS hospitals in England and Wales. Patients aged 60 years and older who received operative treatment for a hip fracture were eligible for inclusion in WHiTE. The prescription of bone protection medications was recorded from participants' discharge summaries, and participant-reported use of bone protection medications was recorded at 120 days following surgery. RESULTS: Of 5456 recruited patients with baseline data, 2853 patients (52%) were prescribed bone protection medication at discharge, of which oral bisphosphonates were the most common, 4109 patients (75%) were prescribed vitamin D or calcium, and 606 patients (11%) were not prescribed anything. Of those prescribed a bone protection medication, only 932 patients (33%) reported still taking their medication 120 days later. CONCLUSION: These data provide a reference for current prescription and adherence rates. Adherence with oral medication remains poor in patients with hip fracture. Cite this article: Bone Joint J 2019;101-B:1402-1407.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Cehic M, Lerner RG, Achten J, et al. Prescribing and adherence to bone protection medications following hip fracture in the United Kingdom: results from the World Hip Trauma Evaluation (WHiTE) cohort study. Bone Joint J. 2019. PMID: 31674239. doi:10.1302/0301-620X.101B11.BJJ-2019-0387.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。